PPARD and colitis: Ligands for PPARδ, including n-3-PUFAs (145, 146), are anti-inflammatory, and at high concentrations PPARδ activation attenuates experimental colitis (147) and intestinal inflammation (148), whereas PPARδ null mice have increased sensitivity to DSS-colitis (149).